Ablation for the management of pulmonary malignancies

American Journal of Roentgenology

Volumn 197, Issue 4, 2011, Pages

  Sofocleous, Constantinos T ^a   Sideras, Panagiotis ^a   Petre, Elena N ^a   Solomon, Stephen B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Ablation; Image guided therapies; Indications; Lung metastases; Minimally invasive treatment; Outcomes; Primary lung cancer; Thermal ablation

Indexed keywords

FLUORINE 18;

ACUTE LUNG INJURY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; DISEASE EXACERBATION; DISEASE FREE SURVIVAL; HEMATOTHORAX; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; LASER THERMOTHERAPY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SURGERY; MICROWAVE THERAPY; OUTCOME ASSESSMENT; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; SURVIVAL TIME; THERAPY EFFECT; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR ABLATION; TUMOR VOLUME;

CATHETER ABLATION; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PATIENT CARE PLANNING; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY, INTERVENTIONAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053226147     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.11.7536     Document Type: Review

References (75)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002; 52:23-47 (Pubitemid 34110469)
2. Rami-Porta R, Ball D, Crowley J, et al.; International Staging Committee; Cancer Research and Biostatistics; Observers to the Committee; Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 2007; 2:593-602 (Pubitemid 47171780)
3. Greene FL. The American Joint Committee on Cancer: updating the strategies in cancer staging. Bull Am Coll Surg 2002; 87:13-15
4. Kaskowitz L, Graham MV, Emami B, Halverson KJ, Rush C. Radiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27:517-523 (Pubitemid 23331116)
5. Kupelian PA, Komaki R, Allen P. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 1996; 36:607-613 (Pubitemid 26404304)
6. Onishi H, Shirato H, Nagata Y, et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2010 Jul 15 [Epub ahead of print]
7. Baba F, Shibamoto Y, Ogino H, et al. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size. Radiat Oncol 2010; 5:81
8. Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010; 28:928-935
9. Louie AV, Rodrigues G, Hannouf M, et al. Stereotactic body radiotherapy versus surgery for medically operable stage I non-small-cell lung cancer: a Markov model-based decision analysis. Int J Radiat Oncol Biol Phys 2010 Oct 5 [Epub ahead of print]
10. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56:106-130
11. Pastorino U. Lung metastasectomy for colorectal cancer. Tumori 1997; 83(suppl 1):S28-S30 (Pubitemid 27207370)
12. [No authors listed]. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases - The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997; 113:37-49
13. Ambrogi MC, Fontanini G, Cioni R, Faviana P, Fanucchi O, Mussi A. Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study. J Thorac Cardiovasc Surg 2006; 131:1002-1006
14. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach." Cancer 2003; 97:3027-3035 (Pubitemid 36676257)
15. McTaggart RA, Dupuy DE. Thermal ablation of lung tumors. Tech Vasc Interv Radiol 2007; 10:102-113 (Pubitemid 350216511)
16. Rose SC. Radiofrequency ablation of pulmonary malignancies. Semin Respir Crit Care Med 2008; 29:361-383
17. Hoffmann RT, Jakobs TF, Lubienski A, et al. Percutaneous radiofrequency ablation of pulmonary tumors: is there a difference between treatment under general anaesthesia and under conscious sedation? Eur J Radiol 2006; 59:168-174 (Pubitemid 44109772)
18. Gómez FM, Palussière J, Santos E, et al. Radiofrequency thermocoagulation of lung tumours: where we are, where we are headed. Clin Transl Oncol 2009; 11:28-34
19. Pua BB, Thornton RH, Solomon SB. Ablation of pulmonary malignancy: current status. J Vasc Interv Radiol 2010; 21(suppl 8):S223-S232
20. Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003; 125:929-937 (Pubitemid 36457516)
21. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9:621-628
22. Dequanter D, Lothaire P. Tumour characteristics and therapeutic results after percutaneous radiofrequency ablation of secondary lung neoplasms. Clin Transl Oncol 2009; 11:393-395
23. Rose SC, Dupuy DE, Gervais DA, et al. Research reporting standards for percutaneous thermal ablation of lung neoplasms. J Vasc Interv Radiol 2009; 20:S474-S485
24. Anderson EM, Lees WR, Gillams AR. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 2009; 32:478-483
25. Steinke K, King J, Glenn D, Morris DL. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr 2003; 27:750-757 (Pubitemid 37087744)
26. Suh RD, Wallace AB, Sheehan RE, Heinze SB, Goldin JG. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation - preliminary results. Radiology 2003; 229:821-829 (Pubitemid 37467589)
27. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000; 214:73-80 (Pubitemid 30019872)
28. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004; 15:463-470 (Pubitemid 38590870)
29. Hoffmann RT, Jakobs TF, Kubisch CH, et al. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results. Eur J Radiol 2010; 73:652-656
30. Goldberg SN, Hahn PF, Tanabe KK, et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis? J Vasc Interv Radiol 1998; 9:101-111 (Pubitemid 28049697)
31. Gillams AR, Lees WR. Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 2008; 18:672-677
32. Ponder E. The coefficient of thermal conductivity of blood and of various tissues. J Gen Physiol 1962; 45:545-551
33. Solazzo SA, Liu Z, Lobo SM, et al. Radiofrequency ablation: importance of background tissue electrical conductivity - an agar phantom and computer modeling study. Radiology 2005; 236:495-502 (Pubitemid 41023432)
34. Vogl TJ, Fieguth HG, Eichler K, et al. Laser-induced thermotherapy of lung metastases and primary lung tumors [in German]. Radiologe 2004; 44:693-699 (Pubitemid 39062362)
35. Vogl TJ, Straub R, Lehnert T, et al. Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy (LITT) and radiofrequency ablation (RFA), and a literature review [in German]. Rofo 2004; 176:1658-1666 (Pubitemid 39486498)
36. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radio-frequency energy. Radiology 2000; 217:633-646
37. Nikfarjam M, Muralidharan V, Christophi C. Mechanisms of focal heat destruction of liver tumors. J Surg Res 2005; 127:208-223 (Pubitemid 41080636)
38. Goldberg SN, Gazelle GS, Halpern EF, Rittman WJ, Mueller PR, Rosenthal DI. Radiofrequency tissue ablation: importance of local temperature along the electrode tip exposure in determining lesion shape and size. Acad Radiol 1996; 3:212-218
39. Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. RadioGraphics 2005; 25(suppl 1):S69-S83 (Pubitemid 41686063)
40. Gabriel S, Lau RW, Gabriel C. The dielectric properties of biological tissues. II. Measurements in the frequency range 10 Hz to 20 GHz. Phys Med Biol 1996; 41:2251-2269 (Pubitemid 26376902)
41. Brace CL, Hinshaw JL, Laeseke PF, Sampson LA, Lee FT Jr. Pulmonary thermal ablation: comparison of radiofrequency and microwave devices by using gross pathologic and CT findings in a swine model. Radiology 2009; 251:705-711
42. Yu NC, Raman SS, Kim YJ, Lassman C, Chang X, Lu DS. Microwave liver ablation: influence of hepatic vein size on heat-sink effect in a porcine model. J Vasc Interv Radiol 2008; 19:1087-1092
43. Knappe V, Mols A. Laser therapy of the lung: biophysical background [in German]. Radiologe 2004; 44:677-683 (Pubitemid 39062359)
44. Gage AA, Baust J. Mechanisms of tissue injury in cryosurgery. Cryobiology 1998; 37:171-186 (Pubitemid 128428624)
45. Hinshaw JL, Lee FT Jr, Laeseke PF, Sampson LA, Brace C. Temperature isotherms during pulmonary cryoablation and their correlation with the zone of ablation. J Vasc Interv Radiol 2010; 21:1424-1428
46. Hinshaw JL, Littrup PJ, Durick N, et al. Optimizing the protocol for pulmonary cryoablation: a comparison of a dual- and triple-freeze protocol. Cardiovasc Intervent Radiol 2010; 33:1180-1185
47. Littrup PJ, Mody A, Sparschu R, et al. Prostatic cryotherapy: ultrasonographic and pathologic correlation in the canine model. Urology 1994; 44:175-183; discussion, 183-184
48. McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990; 25:267-270 (Pubitemid 20085776)
49. Dupuy DE, Zagoria RJ, Akerley W, Mayo-Smith WW, Kavanagh PV, Safran H. Percutaneous radiofrequency ablation of malignancies in the lung. AJR 2000; 174:57-59 (Pubitemid 30030208)
50. Kim SR, Han HJ, Park SJ, et al. Comparison between surgery and radiofrequency ablation for stage I non-small cell lung cancer. Eur J Radiol 2011 Feb 8 [Epub ahead of print]
51. Zemlyak A, Moore WH, Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 2010; 211:68-72
52. Belfiore G, Moggio G, Tedeschi E, et al. CT-guided radiofrequency ablation: a potential complementary therapy for patients with unresectable primary lung cancer - a preliminary report of 33 patients. AJR 2004; 183:1003-1011 (Pubitemid 44185086)
53. King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004; 91:217-223 (Pubitemid 38233968)
54. Steinke K, King J, Glenn DW, Morris DL. Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: tips from preliminary experience. AJR 2004; 183:605-611 (Pubitemid 39145304)
55. Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T. Clinical applications of radio-frequency tumor ablation in the thorax. RadioGraphics 2002; 22(spec no):S259-S269 (Pubitemid 41569711)
56. Vogl TJ, Naguib NN, Eichler K, Lehnert T, Ackermann H, Mack MG. Volumetric evaluation of liver metastases after thermal ablation: long-term results following MR-guided laser-induced thermotherapy. Radiology 2008; 249:865-871
57. Hess A, Palussière J, Goyers JF, Guth A, Aupérin A, De Baère T. Pulmonary radiofrequency ablation in patients with a single lung: feasibility, efficacy, and tolerance. Radiology 2011; 258:635-642
58. Sofocleous CT, May B, Petre EN, et al. Pulmonary thermal ablation in patients with prior pneumonectomy. AJR 2011; 196:1201; [web]W606-W612
59. Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 2006; 30:177-183 (Pubitemid 43850341)
60. Pua BB, Solomon SB. Radiofrequency ablation of primary and metastatic lung cancers. Semin Ultrasound CT MR 2009; 30:113-124
61. Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243:268-275 (Pubitemid 46579719)
62. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13:1529-1537 (Pubitemid 44749666)
63. Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006; 241:275-283 (Pubitemid 44433360)
64. De Baère T, Palussière J, Aupérin A, et al. Mid-term local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006; 240:587-596 (Pubitemid 44098659)
65. Steinke K, King J, Glenn D, Morris DL. Pulmonary hemorrhage during percutaneous radiofrequency ablation: a more frequent complication than assumed? Interact Cardiovasc Thorac Surg 2003; 2:462-465 (Pubitemid 38112783)
66. Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 2007; 109:1397-1405 (Pubitemid 46466568)
67. Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004; 230:125-134 (Pubitemid 37549793)
68. Solomon SB, Thornton RH, Dupuy DE, Downey RJ. Protection of the mediastinum and chest wall with an artificial pneumothorax during lung ablations. J Vasc Interv Radiol 2008; 19:610-615 (Pubitemid 351423658)
69. Sher DJ, Wee JO, Punglia RS. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2011 Feb 10 [Epub ahead of print]
70. Fernando HC, De Hoyos A, Landreneau RJ, et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg 2005; 129:639-644 (Pubitemid 40311325)
71. Laganà D, Carrafiello G, Mangini M, et al. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device. Surg Endosc 2006; 20:1262-1267 (Pubitemid 44259052)
72. Rossi S, Dore R, Cascina A, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 2006; 27:556-563 (Pubitemid 43372530)
73. Ambrogi MC, Dini P, Melfi F, Mussi A. Radiofrequency ablation of inoperable non-small cell lung cancer. J Thorac Oncol 2007; 2(suppl 5):S2-S3 (Pubitemid 47181729)
74. Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004; 11:207-212 (Pubitemid 40486798)
75. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007; 18:393-398 (Pubitemid 46616705)